Trial for Alterity's neurodegenerative drug ATH434 shows reduced disability
An interim trial testing the effects of ATH434 on patients with MSA has yielded positive results for Alterity.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
WGF | Ann: Removal from Official List | 29/04/19 | 0 | 539 | |||
|
|||||||
WGF | Ann: Implementation of Scheme of Arrangement & Director changes | 23/04/19 | 0 | 515 | |||
|
|||||||
WGF | Ann: A LETTER TO WGF SHAREHOLDERS FROM WATERMARK FUNDS MANAGEMENT | 16/04/19 | 0 | 638 | |||
|
|||||||
WGF | Ann: Net Tangible Asset Backing | 12/04/19 | 0 | 413 | |||
|
|||||||
WGF | Ann: Suspension from Official Quotation | 11/04/19 | 0 | 362 | |||
|
|||||||
WGF | Ann: Lodgement of Court Orders with ASIC | 11/04/19 | 0 | 370 | |||
|
|||||||
WGF | News: WGF Watermark Global Leaders Fund Says Federal Court Approved Scheme Of Arrangement | 11/04/19 | 0 | 248 | |||
|
|||||||
WGF | Ann: Amended record date - Federal Court Approves Scheme | 11/04/19 | 0 | 378 | |||
|
See All Discussions